COMP <GO>
HUM vs ILMN // EV/EBITDA & P/E VALUATION
Humana Inc. (NYSE) VS. Illumina Inc. (NASDAQ) • 15-METRIC TALLY: HUM 5
— ILMN 8
▲ EV/EBITDA & P/E VALUATION LEADER: HUM
LAST: $414.50 (-0.73%) • MKT CAP: $50.14B
valuation
18.4x
LAST: $235.99 (-18.64%) • MKT CAP: $43.80B
valuation
47.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HUM VS. ILMN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HUM | ILMN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 66.10% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.30% | 18.20% | -9.90 | ILMN | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 18.4x | 47.5x | -29.10 | HUM | /valuation <GO> |
| Free Cash Flow Yield | 0.75% | 2.13% | -1.38 | ILMN | /fcf-yield <GO> |
| Operating Margin | 2.10% | 18.60% | -16.50 | ILMN | /operating-margins <GO> |
| Net Profit Margin | 0.90% | 19.60% | -18.70 | ILMN | /net-margins <GO> |
| Revenue Growth (YoY) | 10.10% | -0.70% | +10.80 | HUM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.86% | 0.00% | +0.86 | HUM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.03 | 9.52 | -4.49 | ILMN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | ILMN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.9 | 57.1 | -3.20 | ILMN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.88 | 1.16 | -0.28 | ILMN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 39.2x | 47.9x | -8.70 | HUM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $50.14B | $43.80B | $6.34B | HUM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HUM REV | ILMN REV | HUM GROSS % | ILMN GROSS % | HUM FCF | ILMN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $129.66B | $4.34B | — | 66.1% | $375.0M | $931.0M |
| FY 2024 | $117.76B | $4.37B | — | 65.4% | $2.39B | $709.0M |
| FY 2023 | $106.37B | $4.50B | — | — | -$805.8M | $275.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HUM // BETA 0.88
ILMN // BETA 1.16